|
|
Volumn 7, Issue 1, 2011, Pages 54-55
|
|
Development of antidiabetic nanomedicine from stevioside
a
|
|
Author keywords
Nanomedicine; PEG PLA nanoparticles; Stevioside
|
|
Indexed keywords
ANTIDIABETIC;
CONTROLLED RELEASE;
STEVIOSIDES;
THERAPEUTIC POTENTIALS;
MEDICAL NANOTECHNOLOGY;
NANOPARTICLES;
PATHOGENS;
ANTIDIABETIC AGENT;
NANOPARTICLE;
STEVIOSIDE;
SURFACTANT;
GLUCOSIDE;
KAURANE DERIVATIVE;
NANOCAPSULE;
ARTICLE;
ATOMIC FORCE MICROSCOPY;
CONTROLLED RELEASE FORMULATION;
DRUG DEVELOPMENT;
DRUG RELEASE;
DRUG SAFETY;
IN VITRO STUDY;
MICROENCAPSULATION;
NANOMEDICINE;
PARTICLE SIZE;
PHYSICAL CHEMISTRY;
SCANNING ELECTRON MICROSCOPY;
TRANSMISSION ELECTRON MICROSCOPY;
CHEMISTRY;
DIFFUSION;
DRUG FORMULATION;
METHODOLOGY;
ULTRASTRUCTURE;
DIFFUSION;
DITERPENES, KAURANE;
DRUG COMPOUNDING;
GLUCOSIDES;
HYPOGLYCEMIC AGENTS;
NANOCAPSULES;
PARTICLE SIZE;
|
|
EID: 79957723822
PISSN: 15507033
EISSN: 15507041
Source Type: Journal
DOI: 10.1166/jbn.2011.1198 Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|
